My Account Log in

1 option

Assessing the impact of a safe and equitable biosimilar policy in the United States : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, May 2, 2007.

HeinOnline U.S. Congressional Documents Library Available online

View online
Format:
Book
Author/Creator:
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.
Language:
English
Subjects (All):
Biologicals--United States.
Biologicals.
Pharmaceutical biotechnology--United States.
Pharmaceutical biotechnology.
Generic drugs--United States.
Generic drugs.
Physical Description:
1 online resource (vi, 184 p.) ill
Other Title:
Assessing the Impact of a Safe and Equitable Biosimilar Policy in the United States

The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.

Find

Home Release notes

My Account

Shelf Request an item Bookmarks Fines and fees Settings

Guides

Using the Find catalog Using Articles+ Using your account